simplyStocks
Explore all companies →
Agilent Technologies
A · NYSELife Sciences Tools & Diagnostics
The economic chain
Follow the chain left → right, from inputs to end demand. Tap any company to trace its links.
Raw inputs
Equipment
Foundry
Chip design
Software
AI demand
Inputs &supplyAPIs, bioprocess, compone…Discovery &trialsR&D, partners, regulatorsManufacturingDrug substance, fill-fini…ProductsMedicines, therapies, dev…Payers &distributionWholesalers, PBMs, health…Providers &patientsHospitals, surgeons, pati…···Component & reagent suppliersCEMContract electronics makersR&DAgilent R&DREGFDA / EMA / methods bodiesAAgilent TechnologiesBVBIOVECTRAINSInstruments & systemsACGColumns, reagents & servicesDISTLab distributorsPHMPharma & biopharma labsACAAcademia & governmentAPPFood, environmental & chemical labsDXPathology & clinical labs
Company details
Market cap
~$37B
P/E ratio
~25×
Div yield
~0.7%
EPS (FY25 GAAP)
$4.57
Profit margin
~19%
Rev. growth
+6.7%
Revenue (FY25)
$6.95B
Employees
~18,000
In plain English
Agilent makes the instruments and chemistries that scientists use to measure what's in a sample — the chromatographs and mass spectrometers that let pharma companies prove a drug is pure, that find contaminants in food and water, and the reagents pathology labs use to read cancer tissue. Spun out of Hewlett-Packard in 1999, it now earns more than half its money from the recurring columns, consumables and lab services its huge installed base keeps buying.
In simple terms
What Agilent Technologies really sells
Agilent makes the instruments and chemistries that scientists use to measure what's in a sample — the chromatographs and mass spectrometers that let pharma companies prove a drug is pure, that find contaminants in food and water, and the reagents pathology labs use to read cancer tissue. Spun out of Hewlett-Packard in 1999, it now earns more than half its money from the recurring columns, consumables and lab services its huge installed base keeps buying.
Tip · Click any company in the map to learn — in one sentence — what it actually does and why it matters.
Risk read
Moderate
SteadierMore speculative
Why this rating?